MEI Pharma, Inc. (MEIP): Price and Financial Metrics


MEI Pharma, Inc. (MEIP)

Today's Latest Price: $3.02 USD

0.12 (4.14%)

Updated Nov 27 1:00pm

Add MEIP to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 240 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

MEIP Stock Summary

  • MEIP's price/sales ratio is 10.33; that's higher than the P/S ratio of 85.69% of US stocks.
  • Over the past twelve months, MEIP has reported earnings growth of 755.87%, putting it ahead of 98.21% of US stocks in our set.
  • Revenue growth over the past 12 months for MEI Pharma Inc comes in at 465.72%, a number that bests 98.45% of the US stocks we're tracking.
  • Stocks with similar financial metrics, market capitalization, and price volatility to MEI Pharma Inc are ARGX, PXLW, BLDP, ACIA, and SRDX.
  • Visit MEIP's SEC page to see the company's official filings. To visit the company's web site, go to www.meipharma.com.

MEIP Stock Price Chart Interactive Chart >

Price chart for MEIP

MEIP Price/Volume Stats

Current price $3.02 52-week high $4.46
Prev. close $2.90 52-week low $0.72
Day low $2.92 Volume 485,027
Day high $3.03 Avg. volume 1,320,116
50-day MA $2.95 Dividend yield N/A
200-day MA $2.79 Market Cap 339.82M

MEI Pharma, Inc. (MEIP) Company Bio


MEI Pharma, Inc., an oncology company, focuses on the clinical development of drugs for the treatment of cancer. The company was founded in 2000 and is based in San Diego, California.


MEIP Latest News Stream


Event/Time News Detail
Loading, please wait...

MEIP Latest Social Stream


Loading social stream, please wait...

View Full MEIP Social Stream

Latest MEIP News From Around the Web

Below are the latest news stories about MEI Pharma Inc that investors may wish to consider to help them evaluate MEIP as an investment opportunity.

ROSEN, A LEADING LAW FIRM, Reminds MEI Pharma, Inc. Investors of Important October 9 Deadline in Securities Class Action - MEIP

NEW YORK, Sept. 28, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of MEI Pharma, Inc. (NASDAQ: MEIP) between August 2, 2017 and July 1, 2020, inclusive (the "Class Period"), of the important October 9, 2020 lead plaintiff…

PR Newswire | September 28, 2020

MEI Pharma (MEIP) Presents At H.C. Wainwright 22nd Annual Global Investment Conference - Slideshow

The following slide deck was published by MEI Pharma, Inc. in conjunction with this event....

SA Transcripts on Seeking Alpha | September 17, 2020

MEI Pharma Appoints Brian T. Powl As Senior Vice President, Marketing

SAN DIEGO, Sept. 15, 2020 /PRNewswire/ -- MEI Pharma, Inc. (NASDAQ: MEIP) ("MEI"), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced the appointment of Brian T. Powl as senior vice president, marketing, a new role that will report to David…

PR Newswire | September 15, 2020

ROSEN, RECOGNIZED INVESTOR COUNSEL, Reminds MEI Pharma, Inc. Investors of Important October 9 Deadline in Securities Class Action - MEIP

NEW YORK, Sept. 14, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of MEI Pharma, Inc. (NASDAQ: MEIP) between August 2, 2017 and July 1, 2020, inclusive (the "Class Period"), of the important October 9, 2020 lead plaintiff…

PR Newswire | September 14, 2020

MEI Pharma, Inc. (MEIP) CEO Dan Gold on Q4 2020 Results - Earnings Call Transcript

MEI Pharma, Inc. (MEIP) Q4 2020 Earnings Conference Call September 9, 2020 5:00 P.M. ET Company Participants David Walsey - Vice President, Investor Relations and Corporate Communications Brian Drazba - Chief Financial Officer Dan Gold - President and Chief Executive Officer Conference Call Participants Robyn Karnauskas - SunTrust Adam Evertts...

SA Transcripts on Seeking Alpha | September 10, 2020

Read More 'MEIP' Stories Here

MEIP Price Returns

1-mo 14.83%
3-mo 13.96%
6-mo -17.37%
1-year 51.00%
3-year 33.63%
5-year 67.78%
YTD 21.77%
2019 -6.06%
2018 25.71%
2017 45.83%
2016 -10.00%
2015 -62.53%

Continue Researching MEIP

Want to see what other sources are saying about MEI Pharma Inc's financials and stock price? Try the links below:

MEI Pharma Inc (MEIP) Stock Price | Nasdaq
MEI Pharma Inc (MEIP) Stock Quote, History and News - Yahoo Finance
MEI Pharma Inc (MEIP) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.843 seconds.